Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Severson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Virology|December 13, 2002
Ribavirin causes error catastrophe during Hantaan virus replicationWilliam E Severson, Connie S Schmaljohn, Ali Javadian, et al.
Journal of Biomolecular Screening|January 4, 2007
Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound libraryWilliam E Severson, Nice Shindo, Mindy Sosa, et al.
Journal of Biomolecular Screening|September 25, 2008
High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2)William E Severson, Michael McDowell, Subramaniam Ananthan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2Raghuram Kandimalla, Farrukh Aqil, Divyasha Saxena, et al.
Scientific Reports|June 4, 2025
NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse modelEmily R Prantzalos, Jane P Chesser, Judy Songrady Logan, et al.
Virology Journal|January 11, 2013
A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virusDong-Hoon Chung, Blake P Moore, Daljit S Matharu, et al.
Vaccines|November 27, 2021
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated ImmunopathologyJennifer K DeMarco, Joshua M Royal, William E Severson, et al.
Journal of Biomolecular Screening|November 10, 2010
Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screenJoseph A Maddry, Xi Chen, Colleen B Jonsson, et al.
Journal of Medicinal Chemistry|November 18, 2014
Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activityDaljit S Matharu, Daniel P Flaherty, Denise S Simpson, et al.
Vaccines|June 27, 2025
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville CohortLalit Batra, Divyasha Saxena, Triparna Poddar, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Virology|December 13, 2002
Ribavirin causes error catastrophe during Hantaan virus replicationWilliam E Severson, Connie S Schmaljohn, Ali Javadian, et al.
Journal of Biomolecular Screening|January 4, 2007
Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound libraryWilliam E Severson, Nice Shindo, Mindy Sosa, et al.
Journal of Biomolecular Screening|September 25, 2008
High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2)William E Severson, Michael McDowell, Subramaniam Ananthan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2Raghuram Kandimalla, Farrukh Aqil, Divyasha Saxena, et al.
Scientific Reports|June 4, 2025
NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse modelEmily R Prantzalos, Jane P Chesser, Judy Songrady Logan, et al.
Virology Journal|January 11, 2013
A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virusDong-Hoon Chung, Blake P Moore, Daljit S Matharu, et al.
Vaccines|November 27, 2021
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated ImmunopathologyJennifer K DeMarco, Joshua M Royal, William E Severson, et al.
Journal of Biomolecular Screening|November 10, 2010
Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screenJoseph A Maddry, Xi Chen, Colleen B Jonsson, et al.
Journal of Medicinal Chemistry|November 18, 2014
Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activityDaljit S Matharu, Daniel P Flaherty, Denise S Simpson, et al.
Vaccines|June 27, 2025
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville CohortLalit Batra, Divyasha Saxena, Triparna Poddar, et al.
Pageof 2